Genome Editing Market - Global Forecast 2026-2032

The genome editing market is at the forefront of scientific and commercial change, compelling leadership teams to reassess strategies as innovations and regulations reshape possibilities across multiple sectors. This evolving field demands agile decision-making and proactive engagement as its influence reaches new industries and regions.

Market Snapshot: Genome Editing Market Size, Growth, and Outlook

The Genome Editing Market is experiencing robust expansion, moving from USD 5.01 billion in 2025 to USD 5.49 billion in 2026. Projected growth forecasts indicate a compound annual growth rate (CAGR) of 10.96%, with the market anticipated to achieve USD 10.38 billion by 2032. This trajectory reflects accelerating adoption across healthcare, agricultural applications, and industrial biotechnology, with diverse stakeholders driving transformative impacts at local and global levels. The adoption rate is influenced by a combination of technological advancements, competitive investments, and evolving industry requirements.

Scope & Segmentation

Technology Platforms: Includes CRISPR systems (Cas9, Cas12, Cas13), base editing, prime editing, TALENs, zinc-finger nucleases, and meganuclease approaches, covering the spectrum from foundational to next-generation tools.
Application Areas: Addresses agriculture for crop and livestock trait optimization, industrial biotechnology for process improvements, research functions driving scientific discovery, and therapeutic uses in healthcare environments.
End Users: Targets academic research institutions, contract research organizations, and developers in pharmaceutical and biotech sectors engaged in both basic research and translational phases.
Therapeutic Areas: Involves disease intervention strategies for cardiology, oncology, infectious diseases, genetic disorders, and neurological conditions, each bringing unique operational and risk profiles.
Delivery Methods: Considers nonviral delivery such as electroporation and lipid nanoparticles, physical techniques like microinjection and gene guns, and viral vectors relevant for precision and scale.
Geographical Regions: Spans the Americas, Europe, Middle East & Africa, and Asia-Pacific, highlighting factors like local regulation, research networks, and key variables for market access.

Key Takeaways for Decision-Makers

Genome editing technologies are permeating essential workflows in sectors ranging from therapeutic development to production agriculture, changing organizational priorities and expanding partnership ecosystems.
Securing competitive positioning increasingly requires a balance of scientific innovation, resilient supply chains, and early regulatory planning to minimize market entry risks.
Sector-specific adoption drivers differ; agricultural markets focus on sustainability, societal trust, and product longevity, whereas therapeutic stakeholders emphasize safety validation and platform scalability.
Combining genome editing platforms with advanced delivery technologies supports product differentiation and reduces technical risk for new entrants or established players diversifying their pipeline.
Developing transparent public engagement and ethical oversight frameworks strengthens stakeholder confidence, ensuring access to key markets and continued social license to operate.

Tariff Impact: Navigating Supply Chain & Policy Challenges

Recent tariff introductions in 2025 have heightened supply chain complexity in the genome editing industry. Cost structures for critical reagents and capital equipment have shifted, influencing project budgeting and timelines. As manufacturers move toward regionalization, the need for upfront capital increases but offers a buffer against policy disruption. Organizations are facing more administrative hurdles in cross-border collaborations, extending project timelines and introducing new risks to time-sensitive programs. Investors are prioritizing flexible sourcing and supply chain solutions, prompting firms to dual-source materials and increase inventory buffers. Policy-driven incentives for local production are expediting technology transfer but can contribute to regional market fragmentation in the absence of standardized regulation.

Methodology & Data Sources

This report aggregates data from expert interviews, technical literature, regulatory documentation, and company disclosures within the genome editing ecosystem. The market analysis applies segmentation models and scenario-based frameworks, validated through expert review and triangulated data sources to ensure comprehensive accuracy.

Why This Report Matters

Senior executives receive a synthesized view of technical, regulatory, and operational factors crucial for targeted investment and partnership decisions in the genome editing sector.
Segmented analysis and assessment of tariff impacts equip decision-makers with resilient strategy options aligned to market uncertainties and evolving policy challenges.
Focused coverage on platform and regional adoption trends clarifies where to allocate resources for R&D, commercialization, and manufacturing scalability.

Conclusion

Genome editing stands at a pivotal point where operational agility, regulatory expertise, and open stakeholder dialogue drive market success. Organizations synchronizing delivery, supply chain resilience, and forward-thinking partnerships are best positioned for sustained progress and ecosystem leadership.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Genome Editing Market, by Technology

8.1. Base Editing
8.1.1. Adenine Base Editor
8.1.2. Cytosine Base Editor
8.2. Crispr
8.2.1. Cas12
8.2.2. Cas13
8.2.3. Cas9
8.3. Megatal
8.4. Prime Editing
8.5. Talen
8.6. Zfn

9. Genome Editing Market, by Therapeutic Area

9.1. Cardiology
9.2. Genetic Disorders
9.3. Infectious Diseases
9.4. Neurology
9.5. Oncology

10. Genome Editing Market, by Delivery Method

10.1. Nonviral
10.1.1. Electroporation
10.1.2. Lipid Nanoparticles
10.2. Physical Methods
10.2.1. Gene Gun
10.2.2. Microinjection
10.3. Viral Vector

11. Genome Editing Market, by Application

11.1. Agricultural
11.1.1. Crop Improvement
11.1.2. Livestock Improvement
11.2. Industrial Biotechnology
11.2.1. Biofuels
11.2.2. Biomanufacturing
11.3. Research
11.3.1. Basic Research
11.3.2. Drug Discovery
11.4. Therapeutics
11.4.1. Cell Therapy
11.4.2. Gene Therapy

12. Genome Editing Market, by End User

12.1. Academic Institutes
12.2. Contract Research Organizations
12.3. Pharmaceutical Biotech

13. Genome Editing Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Genome Editing Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Genome Editing Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Genome Editing Market
17. China Genome Editing Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Arbor Biotechnologies Inc
18.6. Beam Therapeutics Inc
18.7. Caribou Biosciences Inc
18.8. Century Therapeutics Inc
18.9. CRISPR Therapeutics AG
18.10. Editas Medicine Inc
18.11. GenScript
18.12. Gilead Sciences Inc
18.13. Horizon Discovery Group PLC
18.14. Intellia Therapeutics Inc
18.15. Mammoth Biosciences
18.16. Merck KGaA
18.17. Metagenomi
18.18. Pairwise Plants
18.19. Poseida Therapeutics Inc
18.20. Precision BioSciences Inc
18.21. Prime Medicine Inc
18.22. Regeneron Pharmaceuticals Inc
18.23. Sangamo Therapeutics Inc
18.24. Scribe Therapeutics
18.25. Tessera Therapeutics Inc
18.26. Thermo Fisher Scientific Inc
18.27. Vertex Pharmaceuticals Incorporated
18.28. Verve Therapeutics Inc

List of Figures

FIGURE 1. GLOBAL GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL GENOME EDITING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL GENOME EDITING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL GENOME EDITING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL GENOME EDITING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL GENOME EDITING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL GENOME EDITING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL GENOME EDITING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL GENOME EDITING MARKET SIZE, BY BASE EDITING, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL GENOME EDITING MARKET SIZE, BY BASE EDITING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL GENOME EDITING MARKET SIZE, BY BASE EDITING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL GENOME EDITING MARKET SIZE, BY ADENINE BASE EDITOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL GENOME EDITING MARKET SIZE, BY ADENINE BASE EDITOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL GENOME EDITING MARKET SIZE, BY ADENINE BASE EDITOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL GENOME EDITING MARKET SIZE, BY CYTOSINE BASE EDITOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL GENOME EDITING MARKET SIZE, BY CYTOSINE BASE EDITOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL GENOME EDITING MARKET SIZE, BY CYTOSINE BASE EDITOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL GENOME EDITING MARKET SIZE, BY CRISPR, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL GENOME EDITING MARKET SIZE, BY CRISPR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL GENOME EDITING MARKET SIZE, BY CRISPR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL GENOME EDITING MARKET SIZE, BY CAS12, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL GENOME EDITING MARKET SIZE, BY CAS12, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL GENOME EDITING MARKET SIZE, BY CAS12, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL GENOME EDITING MARKET SIZE, BY CAS13, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL GENOME EDITING MARKET SIZE, BY CAS13, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL GENOME EDITING MARKET SIZE, BY CAS13, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL GENOME EDITING MARKET SIZE, BY CAS9, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL GENOME EDITING MARKET SIZE, BY CAS9, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL GENOME EDITING MARKET SIZE, BY CAS9, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL GENOME EDITING MARKET SIZE, BY MEGATAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL GENOME EDITING MARKET SIZE, BY MEGATAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL GENOME EDITING MARKET SIZE, BY MEGATAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL GENOME EDITING MARKET SIZE, BY PRIME EDITING, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL GENOME EDITING MARKET SIZE, BY PRIME EDITING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL GENOME EDITING MARKET SIZE, BY PRIME EDITING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL GENOME EDITING MARKET SIZE, BY TALEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL GENOME EDITING MARKET SIZE, BY TALEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL GENOME EDITING MARKET SIZE, BY TALEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL GENOME EDITING MARKET SIZE, BY ZFN, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL GENOME EDITING MARKET SIZE, BY ZFN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL GENOME EDITING MARKET SIZE, BY ZFN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL GENOME EDITING MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL GENOME EDITING MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL GENOME EDITING MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL GENOME EDITING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL GENOME EDITING MARKET SIZE, BY GENETIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL GENOME EDITING MARKET SIZE, BY GENETIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL GENOME EDITING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL GENOME EDITING MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL GENOME EDITING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL GENOME EDITING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL GENOME EDITING MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL GENOME EDITING MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL GENOME EDITING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL GENOME EDITING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL GENOME EDITING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL GENOME EDITING MARKET SIZE, BY NONVIRAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL GENOME EDITING MARKET SIZE, BY NONVIRAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL GENOME EDITING MARKET SIZE, BY NONVIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL GENOME EDITING MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL GENOME EDITING MARKET SIZE, BY ELECTROPORATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL GENOME EDITING MARKET SIZE, BY ELECTROPORATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL GENOME EDITING MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL GENOME EDITING MARKET SIZE, BY LIPID NANOPARTICLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL GENOME EDITING MARKET SIZE, BY LIPID NANOPARTICLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL GENOME EDITING MARKET SIZE, BY GENE GUN, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL GENOME EDITING MARKET SIZE, BY GENE GUN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL GENOME EDITING MARKET SIZE, BY GENE GUN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL GENOME EDITING MARKET SIZE, BY MICROINJECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL GENOME EDITING MARKET SIZE, BY MICROINJECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL GENOME EDITING MARKET SIZE, BY MICROINJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL GENOME EDITING MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL GENOME EDITING MARKET SIZE, BY VIRAL VECTOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL GENOME EDITING MARKET SIZE, BY VIRAL VECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL GENOME EDITING MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL GENOME EDITING MARKET SIZE, BY AGRICULTURAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL GENOME EDITING MARKET SIZE, BY AGRICULTURAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL GENOME EDITING MARKET SIZE, BY CROP IMPROVEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL GENOME EDITING MARKET SIZE, BY CROP IMPROVEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL GENOME EDITING MARKET SIZE, BY CROP IMPROVEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL GENOME EDITING MARKET SIZE, BY LIVESTOCK IMPROVEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL GENOME EDITING MARKET SIZE, BY LIVESTOCK IMPROVEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL GENOME EDITING MARKET SIZE, BY LIVESTOCK IMPROVEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL GENOME EDITING MARKET SIZE, BY BIOFUELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL GENOME EDITING MARKET SIZE, BY BIOFUELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL GENOME EDITING MARKET SIZE, BY BIOFUELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL GENOME EDITING MARKET SIZE, BY BIOMANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL GENOME EDITING MARKET SIZE, BY BIOMANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL GENOME EDITING MARKET SIZE, BY BIOMANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL GENOME EDITING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL GENOME EDITING MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL GENOME EDITING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL GENOME EDITING MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL GENOME EDITING MARKET SIZE, BY BASIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL GENOME EDITING MARKET SIZE, BY BASIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL GENOME EDITING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL GENOME EDITING MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL GENOME EDITING MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL GENOME EDITING MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL GENOME EDITING MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL GENOME EDITING MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL GENOME EDITING MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL GENOME EDITING MARKET SIZE, BY CELL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL GENOME EDITING MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL GENOME EDITING MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL GENOME EDITING MARKET SIZE, BY GENE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL GENOME EDITING MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL GENOME EDITING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL GENOME EDITING MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL GENOME EDITING MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL GENOME EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL GENOME EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL GENOME EDITING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL GENOME EDITING MARKET SIZE, BY PHARMACEUTICAL BIOTECH, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL GENOME EDITING MARKET SIZE, BY PHARMACEUTICAL BIOTECH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL GENOME EDITING MARKET SIZE, BY PHARMACEUTICAL BIOTECH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL GENOME EDITING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS GENOME EDITING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. EUROPE GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. EUROPE GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 188. EUROPE GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 189. EUROPE GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 190. EUROPE GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 191. EUROPE GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 192. EUROPE GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 193. EUROPE GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2032 (USD MILLION)
TABLE 194. EUROPE GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 195. EUROPE GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 196. EUROPE GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 197. EUROPE GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 198. EUROPE GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 199. EUROPE GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 202. MIDDLE EAST GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 214. AFRICA GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 215. AFRICA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 216. AFRICA GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 217. AFRICA GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 218. AFRICA GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 219. AFRICA GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 220. AFRICA GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 221. AFRICA GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2032 (USD MILLION)
TABLE 222. AFRICA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 223. AFRICA GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 224. AFRICA GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 225. AFRICA GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 226. AFRICA GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 227. AFRICA GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 228. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 229. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 230. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 233. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 234. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2032 (USD MILLION)
TABLE 236. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 237. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 238. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 239. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 240. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 241. ASIA-PACIFIC GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 242. GLOBAL GENOME EDITING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 243. ASEAN GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 244. ASEAN GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 245. ASEAN GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 246. ASEAN GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 247. ASEAN GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 248. ASEAN GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 249. ASEAN GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 250. ASEAN GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2032 (USD MILLION)
TABLE 251. ASEAN GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 252. ASEAN GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 253. ASEAN GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 254. ASEAN GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 255. ASEAN GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 256. ASEAN GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 257. GCC GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 258. GCC GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 259. GCC GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 260. GCC GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 261. GCC GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 262. GCC GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 263. GCC GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 264. GCC GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2032 (USD MILLION)
TABLE 265. GCC GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 266. GCC GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 267. GCC GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 268. GCC GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 269. GCC GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 270. GCC GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 282. EUROPEAN UNION GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 283. EUROPEAN UNION GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 284. EUROPEAN UNION GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 285. BRICS GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 286. BRICS GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 287. BRICS GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 288. BRICS GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 289. BRICS GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 290. BRICS GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 291. BRICS GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 292. BRICS GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2032 (USD MILLION)
TABLE 293. BRICS GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 294. BRICS GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 295. BRICS GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 296. BRICS GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 297. BRICS GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 298. BRICS GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 299. G7 GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 300. G7 GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 301. G7 GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 302. G7 GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 303. G7 GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 304. G7 GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 305. G7 GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 306. G7 GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2032 (USD MILLION)
TABLE 307. G7 GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 308. G7 GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 309. G7 GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 310. G7 GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 311. G7 GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 312. G7 GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 313. NATO GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 314. NATO GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 315. NATO GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 316. NATO GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 317. NATO GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 318. NATO GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 319. NATO GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 320. NATO GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2032 (USD MILLION)
TABLE 321. NATO GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 322. NATO GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 323. NATO GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 324. NATO GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 325. NATO GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 326. NATO GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 327. GLOBAL GENOME EDITING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 328. UNITED STATES GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 329. UNITED STATES GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 330. UNITED STATES GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 331. UNITED STATES GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 332. UNITED STATES GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 333. UNITED STATES GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 334. UNITED STATES GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 335. UNITED STATES GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2032 (USD MILLION)
TABLE 336. UNITED STATES GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 337. UNITED STATES GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 338. UNITED STATES GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 339. UNITED STATES GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 340. UNITED STATES GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 341. UNITED STATES GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 342. CHINA GENOME EDITING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 343. CHINA GENOME EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 344. CHINA GENOME EDITING MARKET SIZE, BY BASE EDITING, 2018-2032 (USD MILLION)
TABLE 345. CHINA GENOME EDITING MARKET SIZE, BY CRISPR, 2018-2032 (USD MILLION)
TABLE 346. CHINA GENOME EDITING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 347. CHINA GENOME EDITING MARKET SIZE, BY DELIVERY METHOD, 2018-2032 (USD MILLION)
TABLE 348. CHINA GENOME EDITING MARKET SIZE, BY NONVIRAL, 2018-2032 (USD MILLION)
TABLE 349. CHINA GENOME EDITING MARKET SIZE, BY PHYSICAL METHODS, 2018-2032 (USD MILLION)
TABLE 350. CHINA GENOME EDITING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 351. CHINA GENOME EDITING MARKET SIZE, BY AGRICULTURAL, 2018-2032 (USD MILLION)
TABLE 352. CHINA GENOME EDITING MARKET SIZE, BY INDUSTRIAL BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 353. CHINA GENOME EDITING MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
TABLE 354. CHINA GENOME EDITING MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 355. CHINA GENOME EDITING MARKET SIZE, BY END USER, 2018-2032 (USD

Companies Mentioned

The key companies profiled in this Genome Editing market report include:

Arbor Biotechnologies Inc
Beam Therapeutics Inc
Caribou Biosciences Inc
Century Therapeutics Inc
CRISPR Therapeutics AG
Editas Medicine Inc
GenScript
Gilead Sciences Inc
Horizon Discovery Group PLC
Intellia Therapeutics Inc
Mammoth Biosciences
Merck KGaA
Metagenomi
Pairwise Plants
Poseida Therapeutics Inc
Precision BioSciences Inc
Prime Medicine Inc
Regeneron Pharmaceuticals Inc
Sangamo Therapeutics Inc
Scribe Therapeutics
Tessera Therapeutics Inc
Thermo Fisher Scientific Inc
Vertex Pharmaceuticals Incorporated
Verve Therapeutics Inc

Table Information

Report Attribute	Details
No. of Pages	182
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 5.49 Billion
Forecasted Market Value ( USD ) by 2032	$ 10.38 Billion
Compound Annual Growth Rate	10.9%
Regions Covered	Global
No. of Companies Mentioned	25

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3504EUR$3,939USD£3,037GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3779EUR$4,249USD£3,276GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5123EUR$5,759USD£4,440GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6199EUR$6,969USD£5,372GBP

Market Snapshot: Genome Editing Market Size, Growth, and Outlook

Scope & Segmentation

Key Takeaways for Decision-Makers

Tariff Impact: Navigating Supply Chain & Policy Challenges

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Mutation Detection Kits In Genome Editing Market - Global Forecast 2025-2032

Meganuclease Genome Editing Market Report 2025

Genome Editing Market Outlook 2026-2034: Market Share, and Growth Analysis

Rare Disease Genome Editing Market Report 2025

Genome Editing / Genome Engineering - Global Strategic Business Report